Andy Acker, Portfolio Manager on the Global Life Sciences Team, explains the case for active management in the healthcare sector. He also provides an update on the Global Life Sciences Fund, including
Key points:
•Fund performance: key contributors and manager outlook
•Investment process and team update
•Why healthcare now?
•The case for active management: wide disparity between winners and losers in healthcare